Tamarly Intelligence

Who Holds 4D Molecular Therapeutics, Inc. (FDMT)? 158 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 158 holders, $733 million in total.

Largest holders

The 100 largest by value. Change in shares against Q1 2026.

ManagerSharesValueChange
Jupiter Topco LLC5,746,289$76 millionNew13F
RA CAPITAL MANAGEMENT, L.P.5,049,779$67 million+0%13F
BlackRock, Inc.4,546,059$60 million+10%13F
GOLDMAN SACHS GROUP INC4,258,668$57 million+1%13F
NOVO HOLDINGS A/S3,249,178$43 million-11%13F
STATE STREET CORP2,911,109$39 million+8%13F
BVF INC/IL2,879,289$38 million+0%13F
ADAGE CAPITAL PARTNERS GP, L.L.C.2,249,203$30 million+40%13F
Trails Edge Capital Partners, LP2,227,917$30 million+71%13F
VANGUARD CAPITAL MANAGEMENT LLC2,099,055$28 million-4%13F
ARMISTICE CAPITAL, LLC2,000,000$27 million+0%13F
GEODE CAPITAL MANAGEMENT, LLC1,128,466$15 million+6%13F
BANK OF AMERICA CORP /DE/1,120,674$15 million+15%13F
Evergreen Quality Fund GP, Ltd.951,474$13 million+0%13F
Parkman Healthcare Partners LLC948,184$13 million+81%13F
DIMENSIONAL FUND ADVISORS LP730,857$10 million+40%13F
DEUTSCHE BANK AG\710,942$9 million+0%13F
CITADEL ADVISORS LLC687,597$9 million+160%13F
RENAISSANCE TECHNOLOGIES LLC614,573$8 million+6%13F
VANGUARD PORTFOLIO MANAGEMENT LLC579,903$8 million+4%13F
DIADEMA PARTNERS LP571,107$8 millionNew13F
NORTHERN TRUST CORP562,929$7 million+65%13F
ACUTA CAPITAL PARTNERS, LLC507,801$7 millionNew13F
Nuveen, LLC503,071$7 million-10%13F
MORGAN STANLEY503,020$7 million+46%13F
RTW INVESTMENTS, LP475,737$6 million+0%13F
Catalio Capital Management, LP471,254$6 millionNew13F
Schonfeld Strategic Advisors LLC407,470$5 million+303%13F
JPMORGAN CHASE & CO402,137$5 million-3%13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC339,275$5 million+3%13F
Opaleye Management Inc.334,437$4 million+198%13F
VANGUARD FIDUCIARY TRUST CO276,238$4 million+3%13F
Burkehill Global Management, LP275,000$4 million+0%13F
UBS Group AG256,673$3 million+62%13F
Propel Bio Management, LLC252,654$3 million-34%13F
RAYMOND JAMES FINANCIAL INC242,349$3 million-9%13F
FEDERATED HERMES, INC.222,416$3 million-84%13F
ArrowMark Colorado Holdings LLC202,864$3 million+0%13F
Woodline Partners LP200,001$3 million+0%13F
Brevan Howard Capital Management LP176,850$2 millionNew13F
Bank of New York Mellon Corp152,337$2 million+14%13F
Invesco Ltd.150,382$2 million-52%13F
Perigon Wealth Management, LLC146,185$2 million0%13F
Persistent Asset Partners Ltd145,585$2 millionNew13F
VOYA INVESTMENT MANAGEMENT LLC140,200$2 million+209%13F
WELLINGTON MANAGEMENT GROUP LLP128,464$2 million+18%13F
FMR LLC128,316$2 million+83%13F
AMERICAN CENTURY COMPANIES INC114,000$2 million+12%13F
Susquehanna Portfolio Strategies, LLC106,935$1 million+275%13F
Privium Fund Management B.V.90,110$1 million-47%13F
Assenagon Asset Management S.A.83,333$1 million+0%13F
Greenland Capital Management LP72,257$961,018New13F
TWO SIGMA INVESTMENTS, LP69,481$924,097-44%13F
CITIGROUP INC69,212$920,520+164%13F
Man Group plc68,349$909,042+136%13F
Engineers Gate Manager LP68,206$907,140+132%13F
XTX Topco Ltd67,122$892,723-20%13F
Fisher Asset Management, LLC65,751$874,488New13F
RHUMBLINE ADVISERS59,638$793,180+10%13F
Quantinno Capital Management LP58,082$772,491+33%13F
STATE OF WISCONSIN INVESTMENT BOARD56,252$748,152+145%13F
ALPS ADVISORS INC53,056$705,645New13F
TD Asset Management Inc51,482$684,711New13F
AQR CAPITAL MANAGEMENT LLC50,281$668,737+10%13F
Birchview Capital, LP48,505$645,117New13F
PANAGORA ASSET MANAGEMENT INC46,982$624,861-1%13F
Rafferty Asset Management, LLC44,714$594,696-37%13F
D. E. Shaw & Co., Inc.44,354$589,908+85%13F
WELLS FARGO & COMPANY/MN41,732$555,036+128%13F
ALLIANCEBERNSTEIN L.P.55,740$518,939+1%13F
Virtus Investment Advisers, LLC37,055$492,832+47%13F
Allspring Global Investments Holdings, LLC37,200$472,068New13F
COMMONWEALTH EQUITY SERVICES, LLC28,574$380,030+1%13F
Creative Planning28,321$376,669-3%13F
OMERS ADMINISTRATION Corp27,800$369,740New13F
Mitsubishi UFJ Asset Management Co., Ltd.26,644$354,365+14%13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.26,444$349,465+2%13F
MetLife Investment Management, LLC26,057$346,558+6%13F
Squarepoint Ops LLC25,576$340,161-59%13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC25,000$332,500-50%13F
TRUIST FINANCIAL CORP25,000$332,500+0%13F
CANADA PENSION PLAN INVESTMENT BOARD24,700$328,510New13F
Kera Capital Partners, Inc.24,068$320,104+0%13F
BARCLAYS PLC23,825$316,873-6%13F
Rockefeller Capital Management L.P.23,729$315,596+33%13F
Jain Global LLC23,537$313,042New13F
Russell Investments Group, Ltd.23,459$312,004+646%13F
PROFUND ADVISORS LLC22,699$301,897-29%13F
MARSHALL WACE, LLP21,342$283,849+28%13F
Rangeley Capital, LLC20,965$278,835-33%13F
Headlands Technologies LLC19,238$255,865+21%13F
Landing Point Financial Group, LLC18,500$246,050-3%13F
Parallel Advisors, LLC17,887$237,897+0%13F
SEI INVESTMENTS CO16,664$221,633+30%13F
Ballentine Partners, LLC16,359$217,575+0%13F
Vanguard Global Advisers, LLC15,084$200,617-53%13F
Connor, Clark & Lunn Investment Management Ltd.14,899$198,157New13F
AXQ CAPITAL, LP13,964$185,721New13F
Police & Firemen's Retirement System of New Jersey13,831$183,952+39%13F
NEW YORK STATE COMMON RETIREMENT FUND12,543$166,822+0%13F

Questions and answers

How many institutions hold 4D Molecular Therapeutics, Inc.?
158 managers reported 4D Molecular Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 153 the quarter before.
Who is the largest institutional holder of 4D Molecular Therapeutics, Inc.?
Jupiter Topco LLC, with 5,746,289 shares worth $76 million on its 13F for Q2 2026.
How many institutions bought or sold out of 4D Molecular Therapeutics, Inc. in Q2 2026?
31 managers reported a new position and 26 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds 4D Molecular Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/4d-molecular-therapeutics, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.